Peptide record

TPDB13650

Antibacterial Antifungal standard
33 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13650
Antibacterial Antifungal
Anti-infective peptides
AntiBP3 Peptipedia AFP-GFuse Antifungipept CAFPdb dbAMP
standard
No
A 33-aa standard natural multi-activity (Antibacterial and Antifungal) peptide sequence curated from AntiBP3, Peptipedia, AFP-GFuse, and other sources, with an available 3D structural model.
Sequence
TRGRWKRFWRGAGRFFRRHKEKIIRAAVDIVLS
Physicochemical Analysis
C186H298N64O40
NCQMPY
R
4070.82
12.63
12
2
14
+9
5.01
-0.694
73.94
Mammalian: 7.2 hour Yeast: >20 hour E.coli: >10 hour
11000
270.22
2
Residue Composition
number
3
A
8
R
0
N
1
D
0
C
1
E
0
Q
3
G
1
H
3
I
1
L
3
K
0
M
3
F
0
P
1
S
1
T
2
W
0
Y
2
V
Amino Acid Distribution
A: 3 R: 8 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 3 H: 1 I: 3 L: 1 K: 3 M: 0 F: 3 P: 0 S: 1 T: 1 W: 2 Y: 0 V: 2
Chemical Descriptors
33
C186H298N64O40
4070.82
12.63
+9
5.01
-0.694
Evidence Records 42 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1.17-9.38 ug/mL

Target

Escherichia coli ATCC25922 and clinical strains

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against E. coli ATCC25922 and clinical strains (MIC 1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MI
Evidence 2 Activity

Activity

MIC
Antibacterial
1.17 µg/mL

Target

S. dysenteriae

Source & Reference

dbAMP

Other

Active against E. coli ATCC25922 and clinical strains (MIC 1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aure
Evidence 3 Activity

Activity

MIC
Antibacterial
18.75-9.38 µg/mL

Target

K. Pneumoniae

Source & Reference

dbAMP

Other

li ATCC25922 and clinical strains (MIC 1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophili
Evidence 4 Activity

Activity

MIC
Antibacterial
2.34-37.5 ug/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP

Other

1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeru
Evidence 5 Activity

Activity

MIC
Antibacterial
1.17->200 ug/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC
Evidence 6 Activity

Activity

MIC
Antibacterial
9.38 µg/mL

Target

Stenotrophomonas maltophilia ATCC27853

Source & Reference

dbAMP

Other

5-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/
Evidence 7 Activity

Activity

MIC
Antibacterial
4.69 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP

Other

ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml
Evidence 8 Activity

Activity

MIC
Antibacterial
1.17->200 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N
Evidence 9 Activity

Activity

MIC
Antibacterial
9.38 µg/mL

Target

B. cereus

Source & Reference

dbAMP

Other

C27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL
Evidence 10 Activity

Activity

MIC
Antibacterial
1.17 µg/mL

Target

B. subtilis

Source & Reference

dbAMP

Other

aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml
Evidence 11 Activity

Activity

MIC
Antibacterial
1.17 µg/mL

Target

E. faecium

Source & Reference

dbAMP

Other

. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 u
Evidence 12 Activity

Activity

MIC
Antibacterial
2.34 ug/mL

Target

N. asteroides

Source & Reference

dbAMP

Other

), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.
Evidence 13 Activity

Activity

MIC
Antibacterial
37.5 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP

Other

. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (M
Evidence 14 Activity

Activity

MIC
Antibacterial
37.5 ug/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP

Other

. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (M
Evidence 15 Activity

Activity

MIC
Antibacterial
2.34-9.38 µg/mL

Target

Candida albicans

Source & Reference

dbAMP

Other

es (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasil
Evidence 16 Activity

Activity

MIC
Antibacterial
18.75 µg/mL

Target

C. glabrata

Source & Reference

dbAMP

Other

IC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. chole
Evidence 17 Activity

Activity

MIC
Antibacterial
75 µg/mL

Target

C. neoformans

Source & Reference

dbAMP

Other

(MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii
Evidence 18 Activity

Activity

MIC
Antibacterial
75 ug/mL

Target

V. brasiliensis

Source & Reference

dbAMP

Other

38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Up
Evidence 19 Activity

Activity

MIC
Antibacterial
75 ug/mL

Target

V. cholerae

Source & Reference

dbAMP

Other

5 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Updated 7/2021 10/2023
Evidence 20 Activity

Activity

MIC
Antibacterial
75 ug/mL

Target

A. veronii

Source & Reference

dbAMP

Other

75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Updated 7/2021 10/2023
Evidence 21 Activity

Activity

MIC
Antibacterial
9.38 µg/mL

Target

E. tarda

Source & Reference

dbAMP

Other

. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Updated 7/2021 10/2023
Evidence 22 Activity

Activity

MIC
Antifungal
1.17-9.38 ug/mL

Target

Escherichia coli ATCC25922 and clinical strains

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against E. coli ATCC25922 and clinical strains (MIC 1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MI
Evidence 23 Activity

Activity

MIC
Antifungal
1.17 µg/mL

Target

S. dysenteriae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E. coli ATCC25922 and clinical strains (MIC 1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aure
Evidence 24 Activity

Activity

MIC
Antifungal
18.75-9.38 µg/mL

Target

K. Pneumoniae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

li ATCC25922 and clinical strains (MIC 1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophili
Evidence 25 Activity

Activity

MIC
Antifungal
2.34-37.5 ug/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP CAFPdb Antifungipept

Other

1.17-9.38 ug/mL), S. dysenteriae (MIC 1.17 ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeru
Evidence 26 Activity

Activity

MIC
Antifungal
1.17->200 ug/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ug/ml), K. Pneumoniae (MIC 18.75-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC
Evidence 27 Activity

Activity

MIC
Antifungal
9.38 µg/mL

Target

Stenotrophomonas maltophilia ATCC27853

Source & Reference

dbAMP CAFPdb Antifungipept

Other

5-9.38 ug/ml), P. aeruginosa (MIC 2.34-37.5 ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/
Evidence 28 Activity

Activity

MIC
Antifungal
4.69 µg/mL

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ug/mL), Gram+ S. aureus (MIC 1.17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml
Evidence 29 Activity

Activity

MIC
Antifungal
1.17->200 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

17- >200 ug/mL)S. maltophilia ATCC27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N
Evidence 30 Activity

Activity

MIC
Antifungal
9.38 µg/mL

Target

B. cereus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

C27853 (MIC 9.38 ug/ml), P. aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL
Evidence 31 Activity

Activity

MIC
Antifungal
1.17 µg/mL

Target

B. subtilis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

aeruginosa (MIC 4.69 ug/ml), S. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml
Evidence 32 Activity

Activity

MIC
Antifungal
1.17 µg/mL

Target

E. faecium

Source & Reference

dbAMP CAFPdb Antifungipept

Other

. aureus (MIC 1.17->200 ug/ml), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 u
Evidence 33 Activity

Activity

MIC
Antifungal
2.34 ug/mL

Target

N. asteroides

Source & Reference

dbAMP CAFPdb Antifungipept

Other

), B. cereus (MIC 9.38 ug/ml), B. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.
Evidence 34 Activity

Activity

MIC
Antifungal
37.5 µg/mL

Target

Enterococcus faecalis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

. subtilis (MIC 1.17 ug/ml), E. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (M
Evidence 35 Activity

Activity

MIC
Antifungal
37.5 ug/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

. faecium (MIC 1.17 ug/ml), N. asteroides (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (M
Evidence 36 Activity

Activity

MIC
Antifungal
2.34-9.38 µg/mL

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

es (MIC 2.34 ug/mL), E. faecalis (MIC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasil
Evidence 37 Activity

Activity

MIC
Antifungal
18.75 µg/mL

Target

C. glabrata

Source & Reference

dbAMP CAFPdb Antifungipept

Other

IC 37.5 ug/ml), S. epidermidis (MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. chole
Evidence 38 Activity

Activity

MIC
Antifungal
75 µg/mL

Target

C. neoformans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

(MIC 37.5 ug/mL), fungi C. albicans (MIC 2.34-9.38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii
Evidence 39 Activity

Activity

MIC
Antifungal
75 ug/mL

Target

V. brasiliensis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

38 ug/ml), C. glabrata (MIC 18.75 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Up
Evidence 40 Activity

Activity

MIC
Antifungal
75 ug/mL

Target

V. cholerae

Source & Reference

dbAMP CAFPdb Antifungipept

Other

5 ug/ml), C. neoformans (MIC 75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Updated 7/2021 10/2023
Evidence 41 Activity

Activity

MIC
Antifungal
75 ug/mL

Target

A. veronii

Source & Reference

dbAMP CAFPdb Antifungipept

Other

75 ug/ml), aquatic pathogens V. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Updated 7/2021 10/2023
Evidence 42 Activity

Activity

MIC
Antifungal
9.38 µg/mL

Target

E. tarda

Source & Reference

dbAMP CAFPdb Antifungipept

Other

. brasiliensis (MIC 75 ug/mL), V. cholerae (MIC 75 ug/mL), A. veronii (MIC 75 ug/mL), and E. tarda (MIC 9.38 ug/ml). Updated 7/2021 10/2023